Cancer Risk Associations Discovered for 6 Novel Genes
Scientists at deCODE genetics/Amgen and their collaborators have identified six new genes with rare germline variants linked to cancer risk.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Cancer |
Scientists at deCODE genetics/Amgen and their collaborators have identified six new genes with rare germline variants linked to cancer risk.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Emerging & Zoonotic Diseases |
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Cancer |
GRAIL’s REFLECTION study on the Galleri multi-cancer early detection test shows promising early results in U.S. veterans.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Unknown Origin & Other Cancer Types |
Thermo Fisher’s CDx for identifying glioma patients eligible for treatment with Servier Pharmaceuticals’ VORANIGO gets FDA approval.
Read More